Literature DB >> 28364023

RNA activation-independent DNA targeting of the Type III CRISPR-Cas system by a Csm complex.

Kwang-Hyun Park1, Yan An1, Tae-Yang Jung2,3,4, In-Young Baek1, Haemin Noh2, Woo-Chan Ahn1,2, Hans Hebert3,4, Ji-Joon Song2, Jeong-Hoon Kim5, Byung-Ha Oh6, Eui-Jeon Woo7,8.   

Abstract

The CRISPR-Cas system is an adaptive and heritable immune response that destroys invading foreign nucleic acids. The effector complex of the Type III CRISPR-Cas system targets RNA and DNA in a transcription-coupled manner, but the exact mechanism of DNA targeting by this complex remains elusive. In this study, an effector Csm holocomplex derived from Thermococcus onnurineus is reconstituted with a minimalistic combination of Csm1121334151, and shows RNA targeting and RNA-activated single-stranded DNA (ssDNA) targeting activities. Unexpectedly, in the absence of an RNA transcript, it cleaves ssDNA containing a sequence complementary to the bound crRNA guide region in a manner dependent on the HD domain of the Csm1 subunit. This nuclease activity is blocked by a repeat tag found in the host CRISPR loci. The specific cleavage of ssDNA without a target RNA suggests a novel ssDNA targeting mechanism of the Type III system, which could facilitate the efficient and complete degradation of foreign nucleic acids.
© 2017 The Authors.

Entities:  

Keywords:  zzm321990CRISPRzzm321990; zzm321990Thermococcus onnurineuszzm321990; Csm complex; DNase; RNase

Mesh:

Substances:

Year:  2017        PMID: 28364023      PMCID: PMC5412804          DOI: 10.15252/embr.201643700

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  45 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

3.  Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system.

Authors:  Tomas Sinkunas; Giedrius Gasiunas; Christophe Fremaux; Rodolphe Barrangou; Philippe Horvath; Virginijus Siksnys
Journal:  EMBO J       Date:  2011-02-22       Impact factor: 11.598

4.  Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.

Authors:  Giedrius Gasiunas; Rodolphe Barrangou; Philippe Horvath; Virginijus Siksnys
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

Review 5.  CRISPR-based adaptive immune systems.

Authors:  Michael P Terns; Rebecca M Terns
Journal:  Curr Opin Microbiol       Date:  2011-04-29       Impact factor: 7.934

6.  CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3.

Authors:  Edze R Westra; Paul B G van Erp; Tim Künne; Shi Pey Wong; Raymond H J Staals; Christel L C Seegers; Sander Bollen; Matthijs M Jore; Ekaterina Semenova; Konstantin Severinov; Willem M de Vos; Remus T Dame; Renko de Vries; Stan J J Brouns; John van der Oost
Journal:  Mol Cell       Date:  2012-04-19       Impact factor: 17.970

7.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

8.  Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity.

Authors:  Jing Zhang; Christophe Rouillon; Melina Kerou; Judith Reeks; Kim Brugger; Shirley Graham; Julia Reimann; Giuseppe Cannone; Huanting Liu; Sonja-Verena Albers; James H Naismith; Laura Spagnolo; Malcolm F White
Journal:  Mol Cell       Date:  2012-01-05       Impact factor: 17.970

9.  Programmable RNA recognition and cleavage by CRISPR/Cas9.

Authors:  Mitchell R O'Connell; Benjamin L Oakes; Samuel H Sternberg; Alexandra East-Seletsky; Matias Kaplan; Jennifer A Doudna
Journal:  Nature       Date:  2014-09-28       Impact factor: 49.962

10.  The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats.

Authors:  Ibtissem Grissa; Gilles Vergnaud; Christine Pourcel
Journal:  BMC Bioinformatics       Date:  2007-05-23       Impact factor: 3.169

View more
  14 in total

1.  Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.

Authors:  Ning Jia; Charlie Y Mo; Chongyuan Wang; Edward T Eng; Luciano A Marraffini; Dinshaw J Patel
Journal:  Mol Cell       Date:  2018-11-29       Impact factor: 17.970

2.  Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.

Authors:  Lilan You; Jun Ma; Jiuyu Wang; Daria Artamonova; Min Wang; Liang Liu; Hua Xiang; Konstantin Severinov; Xinzheng Zhang; Yanli Wang
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

3.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

4.  RNA activation-independent DNA targeting of the Type III CRISPR-Cas system by a Csm complex.

Authors:  Kwang-Hyun Park; Yan An; Tae-Yang Jung; In-Young Baek; Haemin Noh; Woo-Chan Ahn; Hans Hebert; Ji-Joon Song; Jeong-Hoon Kim; Byung-Ha Oh; Eui-Jeon Woo
Journal:  EMBO Rep       Date:  2017-03-31       Impact factor: 8.807

5.  Cryo-EM structure of Type III-A CRISPR effector complex.

Authors:  Yangao Huo; Tao Li; Nan Wang; Qinghua Dong; Xiangxi Wang; Tao Jiang
Journal:  Cell Res       Date:  2018-11-21       Impact factor: 25.617

6.  Target sequence requirements of a type III-B CRISPR-Cas immune system.

Authors:  Kaitlin Johnson; Brian A Learn; Michael A Estrella; Scott Bailey
Journal:  J Biol Chem       Date:  2019-05-19       Impact factor: 5.157

Review 7.  RNA-targeting CRISPR-Cas systems.

Authors:  Sam P B van Beljouw; Jasper Sanders; Alicia Rodríguez-Molina; Stan J J Brouns
Journal:  Nat Rev Microbiol       Date:  2022-09-28       Impact factor: 78.297

Review 8.  CRISPR-Based Technologies: Impact of RNA-Targeting Systems.

Authors:  Michael P Terns
Journal:  Mol Cell       Date:  2018-11-01       Impact factor: 17.970

9.  The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems.

Authors:  Kawanda Foster; Joshua Kalter; Walter Woodside; Rebecca M Terns; Michael P Terns
Journal:  RNA Biol       Date:  2018-08-01       Impact factor: 4.652

10.  In vivo genome editing using the Cpf1 ortholog derived from Eubacterium eligens.

Authors:  Woo-Chan Ahn; Kwang-Hyun Park; In Seon Bak; Hyung-Nam Song; Yan An; Su-Jin Lee; Mira Jung; Kyeong-Won Yoo; Dae-Yeul Yu; Yong-Sam Kim; Byung-Ha Oh; Eui-Jeon Woo
Journal:  Sci Rep       Date:  2019-09-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.